Search results
Showing results for
Professor Michael Dustin and an international team of collaborators have been awarded a €10M grant from the European Research Council (ERC) to develop a new biotechnology around supramolecular attack particles (SMAPs) engineered to kill cancer cells.
Methods for the development and validation of computable phenotypes based on biobanks and linked real world data
Deadline - Friday 15 May 2026